Adaptin Bio
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3540 Toringdon Way Ste 200, Charlotte, N...Phone Number
(888) 609-1498Website
www.adaptinbio.comRevenue
-Industry
About Adaptin Bio
Adaptin Bio Org Chart
Is Adaptin Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Adaptin Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Adaptin Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Adaptin Bio
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Adaptin Bio recently announced quarterly report
Click to see if Adaptin Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Adaptin Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Adaptin Bio is spiking on competitors!
Funding: Get notified immidiatlly once Adaptin Bio has new funding data
Recommended Actions
Find VP level buyers at Adaptin Bio
Find 2 more new buyers
Company Profile Activity
Activity Insights
Adaptin Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adaptin Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adaptin Bio.
Adaptin Bio News & Media
Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN
CHARLOTTE, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the brain and other difficult-to-reach tissues, today announced that its common shares have been approved for quotation on the OTCQB® Venture Market under the ticker symbol APTN. Quotation on the OTCQB is expected to provide greater access to U.S. investors, improve liquidity, and enhancAdaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to beginAdaptin Bio to Present at the 2026 Sequire Investor Summit in Puerto Rico
CHARLOTTE, N.C., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing precision cancer therapies with targeted delivery to the brain and other tissues, today announced that it will be presenting at the upcoming Sequire Investor Summit 2026. The fourth edition of the Sequire Investor Summit is scheduled to be held on January 20th-22nd, 2026, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico.Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement
Funding expected to support first clinical trial of APTN-101 for the treatment of glioblastoma
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adaptin Bio
Adaptin Bio, is a biotechnology company dedicated to revolutionizing drug delivery. Our focus is on developing innovative technologies that enhance how medications and other therapeutic compounds reach their target destinations within the body.... Read More
